Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02955251
Recruitment Status : Completed
First Posted : November 4, 2016
Last Update Posted : July 20, 2020
Information provided by (Responsible Party):